1 study found for:    22015077 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Unknown  Multicenter, Randomized, Double-Blind, Double-Dummy, Phase 3 Study of the Safety and Efficacy of Ritonavir-Boosted Elvitegravir (EVG/r) Versus Raltegravir (RAL)
Condition: HIV Infection
Interventions: Drug: elvitegravir;   Drug: Raltegravir

Indicates status has not been verified in more than two years